Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

2020 Bulkers Ltd. – Circulates Request for Written Resolution of Shareholders

Hamilton, Bermuda, May 25[th], 2021 2020 Bulkers Ltd. (the “Company”) has today distributed to its shareholders a request for approval by resolution in writing, inter alia, to reduce the Company’s Share Premium account from US$120,232,597 to US$105,232,597.  A copy of the Notice, Information Statement and Written Resolutions are attached.  The request is made to its shareholders with shares registered on the record date May 21[st], 2021. For further queries, please contact:  Magnus Halvorsen, Chief Executive Officer, 2020 Bulkers Management AS  Telephone +47 920 20 111

Citycon Oyj considers issuance of green Capital Securities

CITYCON OYJ   Inside information   25 May 2021 at 10:30 hrsNOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO OR TO ANY PERSON LOCATED IN OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER THE "UNITED STATES"), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Citycon Oyj (“Citycon”) is considering the issuance of euro-denominated green capital securities (“Capital Securities”) in an amount of

BioStock: Invent strengthens patent portfolio with new US approval

The Lund-based medtech company Invent Medic, which develops products that aim to improve women’s health, has received patent approval in the US for Efemia bladder support. The approval, which applies to the current version of the product, further strengthens the company’s patent and design protection portfolio.Read the full article at biostock.se: https://www.biostock.se/en/invent-strengthens-patent-portfolio-with-new-us-approval/This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se

Risk Intelligence A/S signs an agreement for the Risk Intelligence System with a leading engineering and technology company.

Risk Intelligence A/S (“Risk Intelligence” or "the Company") announces today that the company has signed an agreement with a leading technology and engineering company for the Risk Intelligence System.The company is a leader in engineering and technology solutions for the energy industry, employing cutting edge technology at the forefront of energy transition including biofuels, LNG and renewables. Jim Pascoe, Chief Commercial Officer of Risk Intelligence, says:“Their worldwide presence and diverse activities make them an ideal client for us, and we are really looking forward to

Scandinavian ChemoTech remains positive to CE marking despite absent response before deadline

Due to the large number of accumulated applications that all control bodies experience, we do not know for sure if the result will come before 26 May. Despite the lack of a response to the Company's CE marking application, ChemoTech remains positive.At present, all control bodies are struggling to process the final phase of all applications for CE markings under the current MDD regulations, which is a regulatory and strict process without shortcuts. “We know that many shareholders are eagerly awaiting the statement on ChemoTech's CE marking of the IQwave™ and our TSE technology.

BERGENBIO TO PRESENT AT ABGSC SEMINAR

Bergen, Norway, 21[st] May 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce that BerGenBio CEO Mr. Richard Godfrey is presenting at the following virtual conference: ABGSC Life Science Summit, virtual Date: 25 May Live presentation at 10.30hrs CET The presentation will be made available on the Company website: www.bergenbio.com/investors/presentations/ – END – About AXL AXL kinase is a cell membrane receptor and an essential mediator of the

Christel Poncin has been appointed Category & Revenue Growth Director for Paulig's Customer Brands Business Area

Christel Poncin has been appointed Category & Revenue Growth Director within Paulig's Customer Brands commercial team. She is located in Roeselare, Belgium.   Christel Poncin has more than 25 years of experience working at major international Consumer Goods companies like Nielsen, Mondelez, PepsiCo and Danone where she leveraged analytical, customer and shopper centric skills to develop and implement business plans that bring value and competitive advantage. Over the past 7 years, she has worked as VP at Ontex.   “We warmly welcome Christel to this new role. Christel brings a

Dentalum acquires Solna Dental and Solna Dental Arenatandläkarna

Dentalum acquires Solna Dental and Solna Dental Arenatandläkarna and thereby strengthen its position and accessibility in the Stockholm region.As of June 1, 2021, Solna Dental and Solna Dental Arenatandläkarna will become part of the Dentalum group. The clinics were founded about 15 years ago by Dani Toutoundji and have since inception provided excellent service and quality dental care at a good price to its patients. In total, the Dentalum Group now consists of 15 clinics located in six regions in Sweden. · Dentalum approached me over a year ago and by that time I had already been

Clavister - Capital Markets Day 2021

Örnsköldsvik, Sweden, 25 May 2021. Clavister, a leader in high-performance cybersecurity solutions, invites shareholders, investors, analysts and other stakeholders to its virtual Capital Markets Day on 16 June, 2021.During the event, members from the management team will provide an update on Clavister's strategy and initiatives to drive further growth, followed by a live Q&A session where the audience can ask questions to the presenters. Date: Wednesday, 16 June, 2021Time: 10:00 CET – 12:00 CET The presentations will be held in English and can be viewed live or recorded at:https:/

Caverion participates in the urban transformation of Kiruna, Sweden when LKAB builds new police facilities

Caverion Corporation Investor news 25 May at 10.00 a.m. EESTCaverion participates in the urban transformation of Kiruna, Sweden when LKAB builds new police facilities The town of Kiruna in Northern Sweden is under a historical urban transformation as the town center is to be moved three kilometers to the east, to create land space for mining company LKAB:s iron ore mining. About 20 buildings are being moved as such but there will be many new buildings, such as new facilities for the Swedish Police Authority in Kiruna. The new police facilities will be built in Kiruna's new city center

Nordic Capital launches ESG-linked credit facility

Nordic Capital today announced the launch of its first credit facility linked to ESG targets and requirements. The revolving facility strongly underlines Nordic Capital’s ongoing commitment to integrating sustainability into its own business model as well as into its investments. It supports Nordic Capital’s most recent Fund X, which has over EUR 6 billion of investor commitments and the credit facility will now be subject to specific ESG targets. This initiative allows Nordic Capital to take an important stride towards delivering on the key commitments of its Responsible Investment Policy.

UPM Specialty Papers presents UPM Asendo Pro – a multifunctional, fibre-based packaging solution

(UPM, Helsinki, 25 May 2021 at 10:00 EEST) – UPM Specialty Papers is strengthening its already comprehensive selection of sustainable and recyclable packaging papers. Known for its high expertise in technically demanding papers, UPM Specialty Papers now introduces an advanced fibre-based barrier paper – UPM Asendo[TM] Pro.  The latest example of cutting-edge packaging solutions is UPM Asendo Pro – a barrier paper made from renewable materials. UPM Asendo Pro is a two-side coated paper that provides multiple advantages as an easily recyclable monomaterial. UPM Asendo Pro’s print side

ORKLA ASA – Contemplating NOK senior unsecured green bond issuance

Orkla ASA has mandated DNB Markets, Handelsbanken Capital Markets and SEB as Joint Lead Arrangers to arrange a virtual investor meeting on 26[th] of May 2021 where we will present the company and our newly established green bond framework. Subject to market conditions, one or several NOK denominated senior unsecured green bond issues with expected tenor(s) of 5-10 years may follow.SEB has been the Sole Structuring Advisor of Orkla’s green bond framework.   Orkla ASA Oslo, 25 May 2021   Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

Omnicar Holding Q1 2021 report

Highlights - On track to monthly guidance of SEK 2,1 mill in revenue from December 2021 (April revenue was SEK 1,35 mill)For further details and presentation, please sign up for earnings call at 14.30 today - Sign up here  https://hcandersencapital643.clickmeeting.com/omnicar-praesentation-af-q1-kvartalsregnskabet/register Q1 (2021-01-01 - 2021-03-31)   ·Total revenue and other income SEK 3 395 thousand · Q1 loss before tax and interest net SEK -2 366 thousand During

Sport & Outdoor Industry expert Markus Hefter joins Polygiene

Polygiene announces the appointment of the Sport and Outdoor Industry and ISPO veteran Markus Hefter as Commercial Director for the EMEA region. After over 20 years of leading roles in the live communications & events industry he is now joining the team at Polygiene - his latest role being Exhibition Group Director for ISPO Munich, the world's leading trade fair for the sports business OutDoor by ISPO, the largest annual European trade fair for the outdoor sector. As Commercial Director for EMEA he can take advantage of his extensive network and long experience in the global Sports and

Changes in SEB’s Group Executive Committee

Mats Holmström, currently Head of Corporate Banking in SEB’s Large Corporates & Financial Institutions division, has been appointed Chief Risk Officer (CRO) in SEB and member of the Group Executive Committee. He succeeds Magnus Agustsson who will leave SEB. “Mats Holmström has a long and well-established track record in SEB. His extensive knowledge of the bank will be critical as he assumes the role as CRO, prudently defining and managing SEB’s risks,” says Johan Torgeby, President and CEO of SEB. “I want to thank Magnus for the valuable contributions he has made as CRO and member of the

Atlas Copco has acquired a New York based supplier of medical gas systems

Nacka, Sweden, May 25, 2021: Atlas Copco has acquired the operating assets of Medigas Service & Testing Co. Inc. (Medigas). The company services, sells, verifies, and installs piped medical and laboratory gas equipment and systems.The company is privately owned and is an authorized BeaconMedaes representative of medical and laboratory equipment, installation, verification and services.  The company has six employees and is located in Ronkonkoma, New York State. They serve the healthcare and laboratory sectors in the area. “We have a long history of working with Medigas”, said Vagner

INITIATOR PHARMA: INTERIM REPORT JANUARY- MARCH 2021

Business highlights in Q1 2021 · On January 14[th] the EGM approved the proposed convertible financing agreement with MAC Clinical Research, covering up to SEK 23 million (approx. DKK 17 million) of the clinical trial costs for the planned Phase 2b trial with IPED2015 in Erectile Dysfunction. Significant events after this reporting period­ · On April 13[th] it was announced a proposal for a directed issue and fully guaranteed preferential rights issue of total SEK 60 million to expand into new orphan drug indication, led by long-term investors Linc AB and Adrigo Asset

Medivir announces the design of its upcoming MIV-818 combination study

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced the details of its upcoming phase 1/2a combination study with the company's leading candidate drug, MIV-818, against liver cancer. The unique mechanism of action of MIV-818 makes it attractive to be combined with a multitude of other targeted and non-targeted drugs for the treatment of hepatocellular carcinoma. In the upcoming combination study, MIV-818 will be administered in two combinations, either with lenvatinib, a tyrosine kinase inhibitor or pembrolizumab, an anti-PD-1 check-point inhibitor. The planned trial

Nordic Choice Hotels Launches the Nordic Region's First 5G-connected Hotel in Collaboration with Tele2 and Speeron

In collaboration with Tele2 and IT partner Speeron, the Nordic region's first 5G-connected hotel is now being launched at Comfort Hotel Xpress in Stockholm. With 5G, Nordic Choice will, in addition to fast connection in the rooms, be able to offer guests new smart solutions and improved hotel experiences.Nordic Choice Hotels is the first hotel company in the Nordic region that can offer guests 5G, beginning with Comfort Hotel Xpress Stockholm.  Initially. the mobile technology of the future will be available in 20 of the hotel’s 257 rooms, which means that guests can already test the

Everfuel launches plan for Danish hydrogen fueling network

Herning, Denmark, 25 May 2021 – Everfuel A/S today launched the company’s H2 station roll-out plan for Denmark targeting up to 19 strategically positioned fueling sites for zero emission transport by end of 2023. The plan is the third and final section of the Everfuel’s Scandinavian green hydrogen fueling strategy for trucks, buses and cars connecting the main traffic corridors in Sweden, Norway and Denmark. The Danish network will comprise of sites developed by Everfuel, including the fueling stations Esbjerg, Kolding, Aarhus and Korsør which Everfuel today operates and the high-

TePe Sustainability Report 2020 – making progress for a healthier future

TePe’s Sustainability Report 2020 reflects the company’s high ambitions and actions for health awareness, increased circularity, and a reduced carbon footprint.“We want to be a positive force, creating solutions for a healthier future and offering value to our customers. Our ambition is manifested through actions such as setting a climate neutrality target for product and packaging, striving for increased circularity throughout our operations and raising health awareness through education“, says Helena Ossmer Thedius, Marketing & Innovation Director. In 2020, TePe took many significant

Cyxone appoints Carl-Magnus Högerkorp as COO strengthening immunology core competencies

Cyxone today announces that Carl-Magnus Högerkorp is appointed new COO in the company from May 20th, 2021. With broad experience from work within the field of immunology and autoimmune diseases, as well as extensive international experience and previous management roles in the biotech sector, Carl-Magnus is an important part of Cyxone’s continued ambition to strengthen and develop the company.Carl-Magnus holds a PhD in immunology from Lund University, as well as an MBA from Lund University School of Economics and Management. He started his career with a postdoc position at the Vaccine

There are no items matching the current filter
There are no more items matching the current filter
Back to top